Clostridium botulinum C3 Exoenzyme and Studies on Rho Proteins

2008 ◽  
pp. 71-83 ◽  
Author(s):  
C. D. Nobes ◽  
A. Hall
2001 ◽  
Vol 280 (3) ◽  
pp. G381-G388 ◽  
Author(s):  
K. S. Murthy ◽  
H. Zhou ◽  
J. R. Grider ◽  
G. M. Makhlouf

The identity of G proteins mediating CCK-stimulated phospholipase D (PLD) activity was determined in intestinal smooth muscle cells. CCK-8 activated Gq/11, G13, and G12, and the monomeric G proteins Ras-homology protein (RhoA) and ADP ribosylation factor (ARF). Activation of RhoA, but not ARF, was mediated by G13 and inhibited by Gα13 antibody. CCK-stimulated PLD activity was partly mediated by RhoA and could be inhibited to the same extent (47 ± 2% to 53 ± 6%) by 1) a dominant negative RhoA mutant, 2) RhoA antibody or Gα13 antibody, and 3) Clostridium botulinum C3 exoenzyme. PLD activity was also inhibited by ARF antibody, and the effect was additive to that of RhoA antibody or C3 exoenzyme. PLD activity was inhibited by calphostin C, bisindolylmaleimide I, and a selective protein kinase C (PKC)-α inhibitor; the inhibition was additive to that of ARF and RhoA antibodies and C3 exoenzyme. In contrast, activated G12 was not coupled to RhoA or ARF, and Gα12 antibody augmented PLD activity. Thus agonist-stimulated PLD activity is mediated additively by G13-dependent RhoA and by ARF and PKC-α and is modulated by an inhibitory G12-dependent pathway.


Toxins ◽  
2015 ◽  
Vol 7 (2) ◽  
pp. 380-395 ◽  
Author(s):  
Astrid Rohrbeck ◽  
Leonie von Elsner ◽  
Sandra Hagemann ◽  
Ingo Just

1995 ◽  
Vol 308 (3) ◽  
pp. 853-858 ◽  
Author(s):  
M Aepfelbacher ◽  
M Essler ◽  
K Luber De Quintana ◽  
P C Weber

To test the role of Rho GTP-binding proteins in growth regulation of human myelomonocytic tumour cells we used recombinant C3 exoenzyme of Clostridium botulinum to specifically ADP-ribosylate and inactivate Rho proteins in situ. In homogenates of HL60 cells, the C3 exoenzyme [32P]ADP-ribosylated one protein that was identified as RhoA by immunoblot and two-dimensional gel electrophoresis. [32P]ADP ribosylation of RhoA in HL60 homogenates in vitro was reduced to 10-20% when cells in culture were pretreated with C3 exoenzyme (10 micrograms, 24 h), indicating that 80-90% of RhoA could be ADP-ribosylated in situ. The C3 exoenzyme inhibited HL60 cell proliferation by up to 80% and the degree of growth inhibition correlated with the amount of in situ ADP-ribosylated RhoA in a time- and dose-dependent manner. Cell cycle analysis demonstrated that the C3 exoenzyme-treated HL60 cells accumulated in mitosis, and nuclear staining revealed binucleated cells. These findings suggest that RhoA has a key role in human myelomonocytic tumour cell growth by regulating cytoplasmic division.


2005 ◽  
Vol 102 (15) ◽  
pp. 5357-5362 ◽  
Author(s):  
K. P. Holbourn ◽  
J. M. Sutton ◽  
H. R. Evans ◽  
C. C. Shone ◽  
K. R. Acharya

Sign in / Sign up

Export Citation Format

Share Document